Managing Partner, Sean Russell, will be joining other biotech and regulatory authority representatives on a panel discussion at the Alliance for Regenerative Medicine’s EU event, Meeting on the Med representing the academic and not-for-profit perspective on behalf of Fondazione Telethon.

Regulatory Convergence for ATMPs: Building Global Standards
{Salone dei Cavalieri, Section 3&4}

April 16 | 9:45am – 10:30am

Moderator:

Anne-Virginie Eggimann, Chief Regulatory Officer, Tessera Therapeutics

Speakers:

Julian Beach, Executive Director Healthcare Quality and Access, MHRA

Sol Ruiz, Ph.D., Head, Unit of Biotechnology and Advanced Therapies, Spanish Medicines Agency

Sean Russell, Head of Regulatory Affairs, Fondazione Telethon

We’re pleased to be providing regulatory insights on this residential course aimed at those developing treatments for children and young adults with cancer.

Fireside Chat: Non-Profit/Alliance Updates

14:00-15:05 Tuesday, 10 June, 2025, Salon D

Sean Russell will join Barbara Bonamassa (Italian Medicines Agency, AIFA) and Diane Blumenthal (Dianthus Biopharma Consulting, LLC) to explore how non-profit entities are navigating the challenges of bringing ATMPs to patients in desperate need.

Daniel Rabbie, Partner will be leading The Organisation for Professionals in Regulatory Affairs (TOPRA) Masterclass in Cell, Tissue & Gene Therapies. This 3-day course is designed for regulatory affairs professionals to develop their understanding of all aspects of the regulation of advanced therapy medicinal products, providing real-world examples from a variety of industry experts.